PlainPharmaWatch

CMS Open Payments · Tool

iotaMotion, Inc. vs PENTAX of America, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

PENTAX of America, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 642, versus 552 for the other company. Its single largest recorded recipient represents 15.5% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

iotaMotion, Inc.
HHI 552 · top recipient 11.7%
Ranked #1,258 of 1,838 companies by HHI
PENTAX of America, Inc.
HHI 642 · top recipient 15.5%
Ranked #1,202 of 1,838 companies by HHI

Payment Overview

Company A

iotaMotion, Inc.

Total Payments
$1.0M
% of Industry
0.0%
Transactions
164
Avg per Transaction
$6.3K
Recipients
161
Avg per Recipient
$6.4K
Payment Types
4
Top Payment Type
Consulting Fee
Total Payments
$1.0M
% of Industry
0.0%
Transactions
664
Avg per Transaction
$1.6K
Recipients
638
Avg per Recipient
$1.6K
Payment Types
7
Top Payment Type
Grant

Highlighted values indicate the higher figure for each metric.

Total payments compared

iotaMotion, Inc. vs PENTAX of America, Inc. - total reported payments in CMS Open Payments PY2024

iotaMotion, Inc.$1.0MPENTAX of America, Inc.$1.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

iotaMotion, Inc.

Consulting Fee $17.6K

47.2%

Food and Beverage $9.4K

25.2%

Travel and Lodging $6.3K

16.7%

Education $4.1K

10.9%

PENTAX of America, Inc.

Grant $136.9K

37.1%

Travel and Lodging $72.9K

19.8%

Long-Term Medical Supply or Device Loan $68.1K

18.4%

Consulting Fee $60.9K

16.5%

Food and Beverage $26.8K

7.3%

Compensation for Services Other Than Consulting $3.2K

0.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

iotaMotion, Inc.

  1. 1

    MATTHEW CARLSON

    $4,363.14 · 9 txns

  2. 2

    University Of Iowa Hosp & Clinics

    $3,875.00 · 2 txns

  3. 3

    RICK NELSON

    $3,641.06 · 7 txns

  4. 4

    JAY GANTZ

    $2,181.37 · 4 txns

  5. 5

    ERIC KRAUS

    $1,913.91 · 3 txns

PENTAX of America, Inc.

  1. 1

    Mayo Clinic Hospital

    $57,349.71 · 4 txns

  2. 2

    Cleveland Clinic Hospital

    $38,674.91 · 2 txns

  3. 3

    Mercy Hospital Of Buffalo

    $27,992.82 · 12 txns

  4. 4

    Resnick Neuropsychiatric Hospital At

    $27,804.19 · 1 txns

  5. 5

    SHELBY SULLIVAN

    $22,053.37 · 10 txns

Summary Comparison

Metric iotaMotion, Inc. PENTAX of America, Inc.
Total Payments $1.0M $1.0M
% of Industry Total 0.0% 0.0%
Transaction Count 164 664
Avg per Transaction $6.3K $1.6K
Recipient Count 161 638
Avg per Recipient $6.4K $1.6K
Payment Type Count 4 7
Top Payment Type Consulting Fee Grant

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.